40+ years of excellence in custom synthesis and bioconjugation services.
Calculators, design tools, and educational content to support your research.
Custom oligonucleotide synthesis incorporating phosphorus-nitrogen chemistry for internucleotide linkage studies, charge engineering, nuclease-resistance research, molecular recognition and advanced therapeutic or diagnostic designs.
Phosphoramidate chemistry introduces a phosphorus–nitrogen bond into the phosphate or internucleotide linkage region of an oligonucleotide. This changes the electronic, steric and charge environment of the backbone while preserving sequence-programmed nucleobase recognition.
Phosphoramidate is a chemistry family rather than one universal structure. Internucleotide phosphoramidates, non-bridging N-substituted phosphoramidates, terminal phosphoramidates and phosphorodiamidate systems can differ substantially in connectivity, charge, stability and hybridization behavior.
Introduce phosphorus–nitrogen chemistry at defined backbone or terminal positions.
Tune the local phosphate environment through the selected nitrogen substituent.
Evaluate single, patterned, mixed PO/P–N or mixed PS/P–N designs.
Align synthesis, purification and characterization with the intended use.
Representative phosphonoamidate P–N bond architecture. Exact charge, stability and connectivity depend on the selected chemistry.
Start with the natural phosphate-based connection between adjacent nucleotides.
Insert a defined phosphorus–nitrogen bond into the linkage environment.
Evaluate chemistry-dependent effects on charge, stability and molecular recognition.
Optimize placement, purification and QC for the intended research use.
The defining feature is a covalent phosphorus-nitrogen bond. The exact atom replaced and the resulting charge depend on the selected phosphoramidate class.
Important: the schematic above represents a common non-bridging N-substituted phosphoramidate concept. N3′→P5′ phosphoramidates and other P-N structures have different connectivity and should be illustrated separately when offered.
Terminology note: phosphoramidate-modified DNA or RNA and phosphorodiamidate Morpholino oligomers both contain P–N chemistry, but they are structurally different platforms and should not be treated as interchangeable.
A nitrogen-containing substituent replaces a non-bridging oxygen or is introduced at the internucleotide phosphate. N-alkyl, N-sulfonyl, N-aryl and heteroaryl designs can provide distinct charge and steric properties.
The 3′ oxygen connection is replaced with a 3′-nitrogen-to-phosphorus linkage. This is a distinct internucleotide architecture investigated for hybridization, antisense and diagnostic recognition.
P-N chemistry can be introduced at a 5′ or 3′ terminal phosphate for ligand attachment, labeling, cleavable linker development or specialized conjugation.
Phosphorodiamidate structures contain two P-N bonds. PMOs combine phosphorodiamidate linkages with morpholine rings and represent complete backbone reengineering rather than a localized DNA or RNA phosphate modification.
Introduce one or several defined P-N positions to study local effects on charge, stability, hybridization or enzyme recognition.
Distribute P-N linkages within a region or across the sequence to evaluate cumulative backbone effects.
Use phosphorodiamidate Morpholino architecture when complete replacement of the ribose-phosphate backbone is required.
Specify bridging or non-bridging connectivity, the nitrogen substituent and whether the chemistry is monoamidate or diamidate.
Single, terminal, patterned or extensive incorporation can produce different effects on hybridization, charge and manufacturability.
Some P-N linkages create or retain stereogenic phosphorus centers; stereochemical control or mixture characterization may be relevant.
DNA, RNA, mixed sequences, neighboring sugar modifications and local base composition can influence performance.
The P-N bond and nitrogen substituent must tolerate coupling, oxidation, cleavage and deprotection conditions.
Therapeutic, diagnostic, conjugation and mechanistic projects may require different purification and analytical packages.
Provide the exact P-N connectivity or literature reference.
Choose single, patterned, terminal or extensive incorporation.
Assess monomers, protecting groups, oxidation and deprotection.
Develop the solid-phase or post-synthetic route.
Select RP-HPLC, IE-HPLC or project-specific purification.
Confirm identity, purity and P-N integrity.
Evaluate selected P-N linkages or phosphorodiamidate systems for steric blocking, splice switching, charge control and backbone stability studies.
Study effects on probe hybridization, mismatch discrimination, primer behavior and nuclease resistance in assay development.
Use terminal phosphoramidate formation to connect phosphate-bearing oligonucleotides with amines, ligands or reporter groups.
Investigate how P-N connectivity, charge and stereochemistry influence duplex structure, enzymes and biological recognition.
Develop charge-adjusted, functionalized or orthogonal oligonucleotide architectures for synthetic biology and molecular materials research.
Performance note: P-N chemistry should not be described as universally affinity-enhancing, neutral or nuclease-resistant. Outcomes depend on the precise linkage, nitrogen substituent, sequence and placement.
Bio-Synthesis can review customer structures, literature procedures, specialty monomers and supplied reagents, then develop a fit-for-purpose synthesis and analytical strategy.
Bio-Synthesis combines custom backbone linkage development, scientific design support, analytical characterization and cGMP-aligned manufacturing practices to support phosphoramidate programs from feasibility through advanced development.
Bio-Synthesis integrates chemistry feasibility, controlled manufacturing, purification and analytical release within one advanced oligonucleotide program.
Customer-defined P–N structures, mixed-linkage designs and specialty reagent review.
RP-HPLC, IE-HPLC, LC-MS, HR-LC-MS, MALDI-TOF and project-specific testing.
Guidance on structure, placement, compatibility, purification and analytical planning.
Process continuity from feasibility quantities through larger advanced-development supply.
Compare complementary backbone-linkage and complete-backbone reengineering platforms for advanced oligonucleotide design.
Explore service ↗
Scientific-use note: references provide background on distinct P-N chemistries. They do not imply that every phosphoramidate structure has the same synthesis route or performance profile.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.